LDL-c lowering with PCSK9 inhibitor in ASCVD patients without acute ischemic event
Anti-inflammatory therapies for CVD risk prevention
Ulrich Laufs, MD, PhD
Bempedoic acid: effective tool in the toolkit for LDL-c lowering
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Rationale for dietary fat recommendations in ASCVD prevention
Jacob J. Christensen, PhD
Anti-inflammatory effects of GLP-1RA in T2D
Rein Oostveen, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.